ClinicalTrials.Veeva

Menu

Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy (LYMFONI)

C

Centre Hospitalier Universitaire de Besancon

Status

Enrolling

Conditions

Glomerulonephritis, IGA

Treatments

Other: Blood collection
Other: Urine sample

Study type

Interventional

Funder types

Other

Identifiers

NCT05791162
2023/748

Details and patient eligibility

About

This study aims to investigate the relevance of the Tfh/Tfr (Follicular helper T cells/ Follicular regulatory T cells) ratio in patients with IgA nephropathy:

  • To identify a differential expression of the Tfh/Tfr ratio in patients considered stable or progressive
  • To predict, at diagnosis, the clinical evolution of the disease (progressive or stable form) in the first year.

Enrollment

75 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IgA nephropathy histologically proven on renal biopsy according to KDIGO criteria, with 8 permeable glomeruli (patients diagnosed from 2009 with a minimum follow-up for their nephropathy of 5 years (arm 1) or patients diagnosed during the study (arm 2))

Control patients: Lupus or ANCA-associated vasculitis or polycystic kidney disease (arm 3)

Exclusion criteria

  • Legal incapacity or limited legal capacity
  • Subjects with no social security coverage.
  • Pregnancy / No effective contraceptive method

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 3 patient groups

IgA nephropathy in follow-up (arm 1)
Other group
Description:
Diagnosis of IgA nephropathy from 2009, with a minimum follow-up for nephropathy of 5 years
Treatment:
Other: Urine sample
Other: Blood collection
Newly diagnosed IgA nephropathy (arm 2)
Other group
Description:
Diagnosis of IgA nephropathy during the study period
Treatment:
Other: Urine sample
Other: Blood collection
CD163s control (arm 3)
Other group
Description:
Diagnosis of Lupus or ANCA-associated vasculitis or polycystic kidney disease
Treatment:
Other: Urine sample

Trial contacts and locations

1

Loading...

Central trial contact

Charline Vauchy, PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems